CLINICAL TRIALS PROFILE FOR EDARBI
✉ Email this page to a colleague
All Clinical Trials for Edarbi
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00362115 ↗ | Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension | Completed | Takeda | Phase 2 | 2006-05-01 | The purpose of this study is to evaluate the safety, efficacy, and tolerability of azilsartan medoxomil, once daily (QD), in individuals with hypertension. |
NCT00591253 ↗ | Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension | Completed | Takeda | Phase 3 | 2007-10-01 | The purpose of this study is to evaluate the effectiveness and safety of azilsartan medoxomil compared to placebo, once daily (QD), in African-American participants with essential hypertension. |
NCT00591266 ↗ | Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension | Completed | Takeda | Phase 3 | 2007-10-01 | The purpose of this study is to evaluate the efficacy and safety of azilsartan medoxomil, once daily (QD), co-administered with amlodipine in treating individuals with essential hypertension, compared to treatment with amlodipine alone. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Edarbi
Condition Name
Clinical Trial Locations for Edarbi
Trials by Country
Clinical Trial Progress for Edarbi
Clinical Trial Phase
Clinical Trial Sponsors for Edarbi
Sponsor Name